/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Mediwound Ltd

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$17.69 0.0207(2.07%) MDWD at 04 Dec 2025 04:38 PM Biotechnology
Lowest Today 17.355
Highest Today 17.81
Today’s Open 17.355
Prev. Close 17.35
52 Week High 22.51
52 Week Low 14.14
Day’s Range: Low 17.355 High 17.81
52-Week Range: Low 14.14 High 22.51
1 day return -
1 Week return -0.89
1 month return -0.67
3 month return +4.06
6 month return -18.22
1 year return -2.32
3 year return +74.18
5 year return -32.46
10 year return -

Institutional Holdings

Investors Finance Co PLC 8.02

Yelin Lapidot Holdings Management Ltd 7.51

BlackRock Inc 3.96

Rosalind Advisors, Inc. 3.74

T. Rowe Price Associates, Inc. 3.45

iShares Russell 2000 ETF 1.86

Silverberg Bernstein Capital Management LLC 1.36

Essex Investment Management Company, LLC 1.35

Northern Trust Corp 1.25

State Street Corp 1.02

Geode Capital Management, LLC 0.91

ARK Israel Innovative Technology ETF 0.91

ARK Investment Management LLC 0.87

Fidelity Small Cap Index 0.72

Balyasny Asset Management LLC 0.69

UBS Group AG 0.61

iShares Russell 2000 Growth ETF 0.60

Dafna Capital Management LLC 0.59

Sargent Investment Group, LLC 0.50

Vanguard Group Inc 0.50

Morgan Stanley - Brokerage Accounts 0.44

Legato Capital Management LLC 0.40

Millennium Management LLC 0.35

Vanguard Russell 2000 ETF 0.34

1290 Essex Small Cap Growth I 0.31

Citadel Advisors Llc 0.29

Pleiades Small Cap Equity A 0.19

Schwab Small Cap Index 0.18

NT R2000 Index Fund - NL 0.17

iShares Micro-Cap ETF 0.16

NT R2000 Index Fund - DC - NL - 3 0.14

iShares Russell 2000 Small-Cap Idx Instl 0.12

Russell 2500™ Index Fund F 0.12

State St Russell Sm Cap® Indx SL Cl I 0.11

Nuveen Small Cap Blend Idx R6 0.10

Russell 2000 Index Non-Lendable Fund E 0.09

EQ/2000 Managed Volatility IB 0.09

Russell Personalized DI All Cap SMA 0.07

Spartan Small Cap Index Pool K 0.07

LVIP SSgA Small Cap Index Std 0.07

Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 222.45 M

PB Ratio 4.3866

PE Ratio 0.0

Enterprise Value 169.20 M

Total Assets 73.50 M

Volume 89752

Company Financials

Annual Revenue FY23:24966000 25.0M, FY22:26496000 26.5M, FY21:23763000 23.8M, FY20:21763000 21.8M, FY19:31789000 31.8M

Annual Profit FY23:11017000 11.0M, FY22:13165000 13.2M, FY21:8771000 8.8M, FY20:7545000 7.5M, FY19:19940000 19.9M

Annual Net worth FY23:-12430000 -12.4M, FY22:-19599000 -19.6M, FY21:-13551000 -13.6M, FY20:-9601000 -9.6M, FY19:3718000 3.7M

Quarterly Revenue Q3/2025:5429000 5.4M, Q2/2025:5708000 5.7M, Q1/2025:3955000 4.0M, Q3/2024:4355000 4.4M, Q2/2024:5063000 5.1M

Quarterly Profit Q3/2025:896000 0.9M, Q2/2025:1342000 1.3M, Q1/2025:738000 0.7M, Q3/2024:677000 0.7M, Q2/2024:447000 0.4M

Quarterly Net worth Q3/2025:-2652000 -2.7M, Q2/2025:-13318000 -13.3M, Q1/2025:-726000 -0.7M, Q3/2024:-10282000 -10.3M, Q2/2024:-6305000 -6.3M

Fund house & investment objective

Company Information MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Organisation Biotechnology

Employees 111

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow